Growth Metrics

Vericel (VCEL) Current Deferred Revenue: 2015-2018

Historic Current Deferred Revenue for Vericel (VCEL) over the last 2 years, with Dec 2018 value amounting to $566,000.

  • Vericel's Current Deferred Revenue rose 34.76% to $566,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $566,000, marking a year-over-year increase of 34.76%. This contributed to the annual value of $566,000 for FY2018, which is 34.76% up from last year.
  • As of Q4 2018, Vericel's Current Deferred Revenue stood at $566,000, which was up 5.99% from $534,000 recorded in Q3 2018.
  • In the past 5 years, Vericel's Current Deferred Revenue ranged from a high of $566,000 in Q4 2018 and a low of $3,000 during Q4 2016.
  • Over the past 3 years, Vericel's median Current Deferred Revenue value was $443,000 (recorded in 2016), while the average stood at $393,000.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first plummeted by 97.46% in 2016, then spiked by 13,900.00% in 2017.
  • Vericel's Current Deferred Revenue (Quarterly) stood at $118,000 in 2015, then plummeted by 97.46% to $3,000 in 2016, then spiked by 13,900.00% to $420,000 in 2017, then soared by 34.76% to $566,000 in 2018.
  • Its last three reported values are $566,000 in Q4 2018, $534,000 for Q3 2018, and $503,000 during Q2 2018.